2013
DOI: 10.3892/etm.2013.1274
|View full text |Cite
|
Sign up to set email alerts
|

Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway

Abstract: The aim of this study was to investigate the interrelation between basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF) and atrial fibrosis in patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), and to explore the possible molecular mechanisms underlying this interrelation. Twenty patients with RHD who were scheduled for valve replacement were divided into two groups, comprising 10 cases with AF and 10 cases with sinus rhythm (SR). Clinical data were collected and a small… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
20
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 34 publications
(27 reference statements)
0
20
0
Order By: Relevance
“…Selected prior studies suggest that cardiac FGF-2 expression is pro-fibrotic. Li and colleagues documented elevated FGF-2 in fibrotic human atria inferring a pro-fibrotic causative role for FGF-2 [ 25 ]. In addition, Virag and co-workers detected greater infarct scar formation after cardiac-specific over-expression of FGF-2 in post-MI mutant mice [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Selected prior studies suggest that cardiac FGF-2 expression is pro-fibrotic. Li and colleagues documented elevated FGF-2 in fibrotic human atria inferring a pro-fibrotic causative role for FGF-2 [ 25 ]. In addition, Virag and co-workers detected greater infarct scar formation after cardiac-specific over-expression of FGF-2 in post-MI mutant mice [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…At present, there are few studies on the signaling pathways related to the pathogenesis of RHD, and there are only 6 signaling pathways with signi cant research progress: RhoA/Rho-dependent kinase (RhoA/ROCK) signaling pathway,Mitogen-activated protein kinase (MAPK) signaling pathway Protein kinase B/S6 kinase (AKT/S6K) signaling pathway TGF-β1/Smad signaling pathway Wnt signaling pathway and S1PR1/STAT3 signaling pathway [34,[51][52][53][54][55]. And there are only three potential intervention targets found in these signaling pathway studies: Intervene in the expression of interferon (IFN)-γ and tumour necrosis factor (TNF)-α to regulate extracellular matrix remodeling to reduce heart damage caused by RHD; Intervene in AKT/S6K signaling pathway to inhibit TGF-β1-induced broblasts; Intervene in the S1PR1/STAT3 signaling pathway to reduce RHDinduced valvular damage.…”
Section: Discussionmentioning
confidence: 99%
“…Atrial fibrillation (AF) is becoming more common in patients with cardiovascular diseases, including rheumatic heart disease (RHD), hypertension, coronary heart disease, congenital heart disease, cardiomyopathy and pericardial disease ( 1 ). Atrial fibrillation can severely affect human health; rapid ventricular rates may result in the development of fatal malignant arrhythmia, such as ventricular fibrillation ( 1 ). Another condition induced by AF is mural thrombus, which may lead to the development of major adverse cardiovascular events, including acute myocardial infarction and stroke ( 2 ).…”
Section: Introductionmentioning
confidence: 99%